Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

For that endpoint, two reliable studies were performed on the registered substance, assessing skin and eye irritation.

In the skin irritation study, the aim was to assess the local cutaneous tolerance of the "DIETHYL SEBACATE Batch 1727003" in vivo, in 13 volunteers. Tolerance was studied after a patch test carried out under occlusive conditions and lasting 48 hours. Under the experimental conditions, sample "DIETHYL SEBACATE Batch 1727003" is considered not to be irritant nor corrosive for the skin (score=0).

In the eye irritation study, the aim was the evaluation of the occular irritant potential of "Diethyl sebacate batch 021006" by direct application to rabbit corneal fibrobast monolayers by the neutral red release method. Under the experimental conditions, sample "Diethyl sebacate batch 021006" is considered not to be cytotoxic.

The validity criteria were successful and the study was therefore regarded as acceptable for that endpoint.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2002
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Qualifier:
no guideline followed
Guideline:
other: In vivo test on Human : patch-tests simples 48h
GLP compliance:
no
Remarks:
In vivo study (patch-tests simples 48h)
Type of coverage:
occlusive
Preparation of test site:
not specified
Vehicle:
other: empty cup
Amount / concentration applied:
pure
Duration of treatment / exposure:
48 hours
Observation period:
24 hours after the patch is removed
Number of animals:
test on human
Details on study design:
13 volunteers came to the EUROSAFE premises on the day the test started. They were identified by a 3-letter, 2-digit code. The test product was placed in the corresponding cup. The epidermal tests were then applied to the scapular area of the volunteers' backs. An empty cup was then used as a test control. Forty-eight hours after the application of the epidermal tests, they were delicately removed by the dermatologist and their location delimited with a skin pencil. Any skin reactions were read 30 minutes after the removal of the skin tests. A second reading by the dermatologist was carried out 24 hours after the first reading if a reaction was observed.
Irritation parameter:
overall irritation score
Basis:
other:
Time point:
48 h
Score:
0
Max. score:
0
Interpretation of results:
GHS criteria not met
Conclusions:
the product caused no skin reactions in the 13 volunteers. In this study, with the limitations associated with the protocol (i.e. the inclusion of the limited number of 13 volunteers), the product, in pure mode, was shown to be non-irritating.
Executive summary:

For that endpoint, one reliable study on the registered substance was performed.

In this study, the aim was to assess the local cutaneous tolerance of the "DIETHYL SEBACATE Batch 1727003" in vivo, in 13 volunteers. Tolerance was studied after a patch test carried out under occlusive conditions and lasting 48 hours.

Under the experimental conditions, sample "DIETHYL SEBACATE Batch 1727003" is considered not to be irritant nor corrosive for the skin (score=0).

The validity criteria were successful and the study was therefore regarded as acceptable for that endpoint.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2002
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Qualifier:
no guideline followed
Guideline:
other: National decree 5 April 1971 on official methods of analysis for cosmetics and beauty products
Principles of method if other than guideline:
official method for the evaluation of the irritant potential by direct application of rabbit corneal fibroblasts on monolayers by the neutral red release method
GLP compliance:
not specified
Vehicle:
not specified
Controls:
yes
Amount / concentration applied:
10% - 25% - 50% - 100%
Duration of treatment / exposure:
60 secondes
Duration of post- treatment incubation (in vitro):
Not specified
Number of animals or in vitro replicates:
Not specified
Irritation parameter:
other: percentage of mortality
Value:
0
Negative controls validity:
valid
Positive controls validity:
valid
Interpretation of results:
GHS criteria not met
Conclusions:
In this study, the aim was the evaluation of the occular irritant potential of "Diethyl sebacate batch 021006" by direct application to rabbit corneal fibrobast monolayers by the neutral red release method. Under the experimental conditions, sample "DIETHYL SEBACATE Batch 1727003" is considered not to be cytotoxic.
Executive summary:

For that endpoint, one reliable study on the registered substance was performed.

In this study, the aim was the evaluation of the occular irritant potential of "Diethyl sebacate batch 021006" by direct application to rabbit corneal fibrobast monolayers by the neutral red release method. Under the experimental conditions, sample "Diethyl sebacate batch 021006" is considered not to be cytotoxic.

The validity criteria were successful and the study was therefore regarded as acceptable for that endpoint.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Justification for classification or non-classification